Cookies are essential for the operation of our website. By using our website, you agree to the use of cookies.
This website uses cookies to improve and personalize content, and for tracking and analytics. By clicking "Accept All Cookies", you are providing consent for Exelixis to collect and retain personal data for Exelixis to optimize the use of this website. You can learn more about Exelixis' use of cookies by reviewing Exelixis' Privacy Statement.
Reject Nonessential Cookies Accept All Cookies
Skip to main content

Disable motion


Exelixis Medical Affairs is committed to scientific innovation, education, communication, and research.

Development Program

Cabozantinib Development Program

Our Pipeline

Explore our pipeline

Medical Affairs

Click to go to Resource

Explore Our
Clinical Trials

Clinical Trials